Mustafa Yasser Fakri
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq.
Indian J Clin Biochem. 2024 Apr;39(2):154-167. doi: 10.1007/s12291-023-01147-y. Epub 2023 Aug 1.
The production of harmful free radicals (H-FRs), especially those with oxygen or nitrogen atoms, depends on both internal and environmental causes. The negative effects of H-FRs are greatly alleviated by antioxidant protection. The harmful impact of oxidative stress, or OS, is brought on by a disparity between the defense mechanisms of the body and the creation of H-FRs. Aging is characterized by a slow decline in tissue and organ competence. Age-mediated pathologies start as an aberrant accumulation of H-FRs, which inhibit cells' capacity to divide, repair, and operate, based on the OS theorem of aging. The natural outcome of this situation is apoptosis. These conditions may include skeletal muscle dysfunction, cancer, cardiovascular, chronic hepatitis, chronic renal, and chronic pulmonary disorders. Given the substantial role that OS plays in the progression of many of these illnesses, antioxidant-based therapy may have a favorable impact on how these diseases progress. To ascertain the true efficacy of this therapy strategy, more research is necessary. The aim of this study is to provide an overview of the literature on this challenging issue that is attracting interest.
有害自由基(H-FRs)的产生,尤其是那些含有氧或氮原子的自由基,取决于内部和环境因素。抗氧化保护可大大减轻H-FRs的负面影响。氧化应激(OS)的有害影响是由身体防御机制与H-FRs产生之间的不平衡所导致的。衰老的特征是组织和器官功能的缓慢衰退。根据衰老的OS理论,年龄介导的病理始于H-FRs的异常积累,这会抑制细胞的分裂、修复和运作能力。这种情况的自然结果是细胞凋亡。这些病症可能包括骨骼肌功能障碍、癌症、心血管疾病、慢性肝炎、慢性肾病和慢性肺病。鉴于OS在许多这些疾病的进展中起着重要作用,基于抗氧化剂的治疗可能会对这些疾病的进展产生积极影响。为了确定这种治疗策略的真正疗效,还需要更多的研究。本研究的目的是概述关于这个引起关注的具有挑战性问题的文献。